Lymphoma
Showing all 14 results
-
ALIQOPA (copanlisib) for injection, for intravenous use. Initial U.S. Approval: 2017
Read more -
Atriance (nelarabine) for injection
Read more -
BRUKINSA (zanubrutinib) capsules, for oral use. Initial U.S. Approval: 2019
Read more -
CALQUENCE (acalabrutinib) capsules, for oral use. Initial U.S. Approval: 2017
Read more -
Columvi (glofitamab) for injection
Read more -
COPIKTRA (duvelisib), capsules for oral use. Initial U.S. Approval: 2018
Read more -
GAZYVA (obinutuzumab) injection, for intravenous infusion. Initial U.S. Approval: 2013
Read more -
MONJUVI (tafasitamab-cxix) for injection. FDA-Approved. To treat lymphoma
Read more -
POLIVY (polatuzumab vedotin-piiq) for injection, for intravenous use. Initial U.S. Approval: 2019
Read more -
RYLAZE (asparaginase erwinia chrysanthemi (recombinant) rywn) injection
Read more -
VENCLEXTA (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016
Read more -
XALKORI (crizotinib) capsules
Read more -
ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014
Read more -
ZYNLONTA (loncastuximab tesirine-lpyl) for injection
Read more
